All Gut Microbiome articles – Page 13
-
NewsProbiotic may improve sleep quality: new research findings
A recent study has identified a potential new approach to managing sleep disorders. The research focuses on the role of S-adenosylmethionine (SAM)-producing probiotics in regulating sleep and circadian rhythms.
-
NewsStudy reveals how dextran sulfate sodium-induced colitis exacerbates periodontitis
A new study provides strong evidence that the NOX2/ROS axis plays a key role in the exacerbation of periodontitis in the presence of colitis.
-
NewsCorrecting imbalance with the gut microbiota after stroke could reduce brain inflammation
An imbalance in ligands, which are molecules produced by the body and the gut microbiota, can affect a key receptor protein that plays a role in brain inflammation after stroke, according to researchers.
-
NewsThe gut microbiota-metabolites-brain axis mediates social behavior dysfunction following anaesthesia
New research shows that the anaesthetic Sevoflurane (Sev) influences social functioning via the gut-brain axis, with microbiota-derived bile acids serving as critical mediators in this pathway.
-
NewsHost’s sex plays key role in how gut microbiome evolves with age
Researchers studied how aging affects gut bacteria in a special group of rats generated to have genetic diversity similar to humans. Their research found that both biological sex and mitochondrial DNA—the small set of genes inherited only from mothers—play a key role in how gut bacteria change over time.
-
NewsBacteria invade brain after implanting medical devices
Researchers have discovered that bacteria can invade the brain after a medical device is implanted, contributing to inflammation and reducing the device’s long-term effectiveness.
-
NewsA review of Clostridioides difficile infection and treatments
<i>Clostridioides difficile</i> is a serious nosocomial infection that could cause from mild diarrhea to fatal colitis. Here presents a general overview that describes the current and emerging treatment practices for the prevention of <i>Clostridioides difficile</i> infection and its recourrences.
-
NewsThe relationship between gut microbiota, immunoglobulin A, and vaccine efficacy
Researchers concluded that the close relationship between immunoglobulin A (IgA) deficiency and the gut microbiota overgrowth is closely tied with the pneumococcal vaccine effectiveness in adults, thus providing insights for preventative strategies to enhance the vaccine response.
-
FeaturesUnder the microscope: the gut-brain axis
Research indicates that the trillions of microbes living in our gut significantly influence our cognitive abilities, emotional well-being, and decision-making processes. This fascinating connection, often called the gut-brain axis, has transformed our understanding of mental health and cognitive function.
-
News2025 Gut Microbiota for Health World Summit to spotlight groundbreaking research
The 13th Gut Microbiota for Health World Summit, taking place March 15-16 in Washington, D.C., will reveal how cutting-edge research on gut microbiome science is being applied to clinical practice.
-
NewsFood systems, climate change, and air pollution: Unveiling the interactions and solutions
A recent review delves into the complex relationships among food systems, climate change, and air pollution, highlighting the need for sustainable strategies to address these interconnected global challenges.
-
NewsGut bacterium IDed as key player in healing the colon
Researchers have identified Clostridium scindens, a bacterium that converts primary bile acids into 7α-dehydroxylated bile acids, as a key player in gut healing. Supplementing the gut with this bacterium could improve recovery from colonic injury.
-
NewsNovel enzyme found in gut bacteria could revolutionize prebiotic research
Researchers have discovered a new β-galactosidase enzyme in a human gut bacterium that breaks down and synthesizes previously unexplored glycans, which have prebiotic capabilities to improve gut health.
-
NewsEarly-life gut microbes may protect against diabetes, research in mice suggests
A research discovered that the colonization of a fungus called <i>Candida dubliniensis</i> in the early life gut microbiome of mice, is able to promote growth of pancreatic beta cells in the presence of macrophages to restore blood insulin level and improve metabolic functions, thus reducing risks of type 1 diabetes.
-
NewsEffects of electroacupuncture combined with Chinese herbal medicine on gut microbiota and metabolomics in amyotrophic lateral sclerosis
Studies have highlighted a link between amyotrophic lateral sclerosis (ALS) and gut microbiota. A prospective study aimed to evaluate the effects of electroacupuncture combined with Chinese herbal medicine on gut microbiota and metabolomics in ALS patients.
-
NewsLonger breastfeeding linked to blood-pressure lowering effects of certain infant gut bacteria
An observational study has found that infants who had more diverse bacteria in their gut had lower childhood blood pressure, and this protective association was stronger if they were breastfed for at least six months.
-
NewsAMI member Christopher Stewart named as laureate in 2025 UK Blavatnik Awards for Young Scientists
Applied Microbiology International member Professor Christopher Stewart of Newcastle University has been named as one of three 2025 laureates in the eighth Blavatnik Awards for Young Scientists in the UK.
-
NewsStudy uncovers how low-carb diet drives colorectal cancer development
A new study suggests that a low-carbohydrate diet promotes the growth of a strain of E. coli that produces DNA-damaging colibactin, which drives genetic mutations and predisposes tumour development.
-
NewsA surprising link between Crohn’s disease and the Epstein-Barr virus
A longitudinal study has revealed strong and surprising evidence showing that exposure to Epstein-Barr virus (EBV) can lead to a higher risk of Crohn’s disease. Researchers are now trying to find out the mechanistic actions in their associations.
-
NewsSynthetic microbiome therapy suppresses bacterial infection without antibiotics
A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously difficult-to-treat and potentially life threatening in humans. Clostridioides difficile is a bacterium that can cause severe diarrhea, abdominal pain and colon inflammation.